🔓 Unlock the full profile of Sanjai Saxenaa (Thapar Institute Of Engineering & Technology), including verified contact details, financial insights, and professional associations.
See Sanjai Saxenaa Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: san*****@tha******.com
Mobile: 88865*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Sanjai Saxenaa is the Founder and Chief Scientific Officer (CSO) of AGPHARM BIOINNOVATIONS LLP, established in January 2019, contributing to advancements in agricultural biotechnology.
- Previously, Sanjai served as the Founder and CSO at Thapar Institute of Engineering & Technology since July 2015, playing a crucial role in leadership and strategic development.
- Prior to these roles, Sanjai held the position of Associate Professor (Reader) at Thapar Institute of Engineering & Technology from April 2009 to July 2015, enhancing the educational framework and research capabilities.
- As an Assistant Professor at the same institution from April 2006 to April 2009, Sanjai contributed to curriculum development and mentoring students in engineering disciplines.
- From September 2013 to February 2017, Sanjai was the Coordinator/Head at TIFAC-CORE (Centre for Relevance & Excellence) in Agro and Industrial Biotechnology, fostering innovation and collaboration in biotechnology.
- Between May 2006 and June 2008, Sanjai served as Deputy Coordinator at the Science & Technology Entrepreneurs Park (STEP), supporting entrepreneurial initiatives and technology transfer.
- Sanjai’s career began as a Research Scientist at Thapar Centre for Industrial Research & Development (TCIRD) from September 2000 to March 2002, where foundational research skills were developed.
- Earlier academic experience includes serving as a Junior Research Fellow and Doctoral Student at Rani Durgavati Vishwavidyalaya, Jabalpur, from January 1997 to July 2000, laying the groundwork for a successful academic and research career.